Propanc Biopharma, Inc. (PPCB)
0.19
-0.01
(-6.27%)
USD |
NASDAQ |
Feb 20, 16:00
0.19
0.00 (0.00%)
After-Hours: 20:00
Propanc Biopharma Total Assets (Quarterly) : 15.11M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Lumos Diagnostics Holdings Ltd. | -- |
| Incannex Healthcare, Inc. | 75.01M |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 140.92M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.659M |
| Shareholders Equity (Quarterly) | 10.45M |
| Debt to Equity Ratio | 0.1578 |
| Current Ratio | 2.127 |
| Net Debt Paydown Yield | -1.52% |